ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
2 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
9.8K
|
2.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
ces
|
317 |
73K |
2 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
317
|
73K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Hedging
|
|
ces
|
29 |
8.1K |
1 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
29
|
8.1K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Hedging
|
|
ces
|
29 |
8.1K |
2 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
29
|
8.1K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
ces
|
1.0K |
330K |
1 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
1.0K
|
330K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Sale of PNG Interests
|
|
ces
|
69 |
23K |
0 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
69
|
23K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Notification of cessation of securities - HZN
|
|
ces
|
20 |
5.9K |
3 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
20
|
5.9K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Notification of cessation of securities - HZN
|
|
ces
|
20 |
5.9K |
1 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
20
|
5.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
ces
|
1.0K |
279K |
2 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
1.0K
|
279K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
ces
|
905 |
286K |
14 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
905
|
286K
|
14
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
4 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
HZN |
Re:
DCF cashflow per year
|
|
ces
|
58 |
21K |
0 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
58
|
21K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
1 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
1 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
HZN |
Re:
DCF cashflow per year
|
|
ces
|
58 |
21K |
0 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
58
|
21K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
ces
|
1.6K |
464K |
6 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
1.6K
|
464K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
6 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
9.8K
|
2.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ces
|
9.8K |
2.9M |
3 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
ces
|
1.0K |
279K |
2 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
41 |
13K |
0 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
41
|
13K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
3 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
128
|
39K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
3 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
128
|
39K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
6 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
128
|
39K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
8 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
128
|
39K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
0 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
128
|
39K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
5 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
128
|
39K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
6 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
128
|
39K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
4 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
128
|
39K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Novartis Exiting Roche - Cas$$$ed Up
|
|
ces
|
128 |
39K |
10 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
128
|
39K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
5 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
HZN |
Re:
HZN AGM Voting Intentions
|
|
ces
|
2 |
808 |
0 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
2
|
808
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
41 |
13K |
0 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
41
|
13K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
41 |
13K |
3 |
07/11/21 |
07/11/21 |
ASX - By Stock
|
41
|
13K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
2 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
8 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Change in substantial holding
|
|
ces
|
11 |
3.8K |
0 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
11
|
3.8K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Change in substantial holding
|
|
ces
|
11 |
3.8K |
0 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
11
|
3.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
ces
|
1.5K |
504K |
3 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
1.5K
|
504K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Change in substantial holding
|
|
ces
|
11 |
3.8K |
0 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
11
|
3.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
ces
|
5.4K |
2.7M |
4 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
5.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
HZN |
Re:
"Parabolic Oil" Ahoy?
|
|
ces
|
30 |
12K |
1 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
30
|
12K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
"Parabolic Oil" Ahoy?
|
|
ces
|
30 |
12K |
2 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
30
|
12K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
3 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
0 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
1 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
6 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
2 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
1 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB - A Question of Trust?
|
|
ces
|
297 |
71K |
0 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
297
|
71K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Date of AGM
|
|
ces
|
10 |
3.9K |
2 |
02/10/21 |
02/10/21 |
ASX - By Stock
|
10
|
3.9K
|
2
|
|